Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024
ZUG, Switzerland, and BOSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq:OCS) (“Oculis” or “the Company”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced it will host an in-person R&D Day in Midtown, New York City, on Wednesday, February 28, 2024 from 9:00 AM to 11:00 AM ET. Please click here to attend the event either in-person or virtually. Location details for in-person attendance will be provided upon registration.
Related news for (OCS)
- Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2025 Financial Results
- Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 6.340% Notes due 2030
- Doximity Announces Fiscal 2025 Third Quarter Financial Results
- Oaktree Specialty Lending Corporation Announces First Fiscal Quarter 2025 Financial Results
- Oaktree Specialty Lending Corporation Announces Fourth Fiscal Quarter and Full Year 2024 Financial Results and Declares Quarterly Distribution of $0.55 Per Share